The concept of customized made CAR-plasmid transfected exosomes is not limited to a cure for the hematological CD19 B-cell malignancies but can be possibly utilized for other CD19 B-cell expressing conditions such as in autoimmune diseases. This evidence concerns the gene CD19 and autoimmune disease.